How government price controls are holding back small molecule innovation   ...Middle East

The Hill - News
How government price controls are holding back small molecule innovation  
With the Biden administration focus on implementing the Inflation Reduction Act (IRA), developers of small molecule drugs face an uncertain future.   Small molecule drugs, which play a critical role in treating many diseases, can often be more convenient for patients, and cheaper to develop and manufacture. Medical treatment for heart failure, a condition affecting over 6 million Americans, relies solely on small molecule drugs. With the average heart failure hospitalization lasting four to seven days, one in two patients suffering from breathlessness, and nearly half experiencing difficulty climbing stairs, the burdens of disease weigh heavily upon the patient.   The IRA’s authors

Hence then, the article about how government price controls are holding back small molecule innovation was published today ( ) and is available on The Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( How government price controls are holding back small molecule innovation   )

Apple Storegoogle play

Last updated :

Also on site :